Journal: Cell Death & Disease
Article Title: Super enhancer lncRNA RP11-54O7.17 regulates the proliferation and metastasis of triple-negative breast cancer by targeting lysosomal degradation of S100A4
doi: 10.1038/s41419-025-08072-3
Figure Lengend Snippet: A Expression of S100A4 and p-STAT3 in RP11-54O7.17 overexpressed cells detected by Western blotting, n = 3. B Expression of S100A4 in RP11-54O7.17 overexpressed cells detected by immunofluorescence (White arrows: S100A4 nucleoli enrichment, DAPI micronuclei), n = 3. C Expression of S100A4 in cells transfected with different concentrations of RP11-54O7.17 in vitro, n = 3. D Effect of S100A4 overexpression on the inhibition of cell clone formation induced by RP11-54O7.17 by colony formation assay, n = 3. E Effect of S100A4 overexpression on the inhibition of cell viability induced by RP11-54O7.17 by MTT assay, n = 3. F Effect of S100A4 knocked-down on STAT3 activation, n = 3. G Effect of S100A4 overexpression on STAT3 activation, n = 3. Data for ( D , E ) are presented as mean ± SD, ** P < 0.01, *** P < 0.001.
Article Snippet: Primary antibodies in the study were antibodies against p-STAT3 (1:1000, Cst, #4113), STAT3 (1:1000, Cst, #30835), S100A4 (1:1000, Cst, #13018), HSP70 (1:1000, Santa Cruz, #K2020), GAPDH (1:1000, Cst, #5174), β-tubulin (1:1000, Cst, #2128) and H3 (1:1000, Millipore, #06-599).
Techniques: Expressing, Western Blot, Immunofluorescence, Transfection, In Vitro, Over Expression, Inhibition, Colony Assay, MTT Assay, Activation Assay